We are live on ! Find out more
GPCM

Granite Point Capital Management Portfolio holdings

AUM $4.9M
1-Year Est. Return 38.41%
This Fund
S&P 500
This Quarter Est. Return
+16.89%
1 Year Est. Return
+38.41%
3 Year Est. Return
+124.67%
5 Year Est. Return
+295.96%
10 Year Est. Return
–
AUM
$2.68B
AUM Growth
+$730M
Cap. Flow
+$634M
Cap. Flow %
23.64%
Top 10 Hldgs %
78.07%
Holding
230
New
82
Increased
28
Reduced
42
Closed
51

Top Buys

Rank Stock Value
1
BLUE
bluebird bio
BLUE
+$9.12M
2
ASPN icon
Aspen Aerogels
ASPN
+$6.41M
3
CTAC
Cerberus Telecom Acquisition Corp.
CTAC
+$6.22M
4
QUOT
Quotient Technology Inc
QUOT
+$6.18M
5
ENVX icon
Enovix
ENVX
+$5.67M

Top Sells

Rank Stock Value
1
DKNG icon
DraftKings
DKNG
+$11.1M
2
CDNA icon
CareDx
CDNA
+$10.1M
3
STIM icon
Neuronetics
STIM
+$8.13M
4
AXGN icon
Axogen
AXGN
+$7.95M
5
PYPL icon
PayPal
PYPL
+$5.27M

Sector Composition

Rank Sector Weight
1 Healthcare 2.79%
2 Consumer Discretionary 1.99%
3 Technology 1.3%
4 Communication Services 1.2%
5 Financials 0.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EACPU
151
DELISTED
Edify Acquisition Corp. Units
EACPU
$746K 0.03%
+75,000
New +$764K
PRCH icon
152
Porch Group
PRCH
$1.8B
$708K 0.03%
40,000
-210,000
-84% -$3.73M
AXTI icon
153
AXT Inc
AXTI
$5.57B
$700K 0.03%
+60,000
New +$721K
AGS
154
DELISTED
PlayAGS
AGS
$670K 0.03%
82,913
-6,005
-7% -$42.7K
PDD icon
155
Pinduoduo
PDD
$130B
$669K 0.03%
+5,000
New +$844K
TSM icon
156
TSMC
TSM
$2.18T
$591K 0.02%
+5,000
New +$619K
OBIO icon
157
Orchestra BioMed
OBIO
$252M
$539K 0.02%
48,000
– –
TCRR
158
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$530K 0.02%
24,000
-26,000
-52% -$709K
RYM
159
RYTHM Inc
RYM
$51M
$499K 0.02%
+13
New +$538K
HYRE
160
DELISTED
HyreCar Inc. Common Stock
HYRE
$490K 0.02%
50,000
-114,030
-70% -$1.12M
CTK
161
DELISTED
CooTek (Cayman) Inc. American Depositary Shares, each representing 650 Class A Ordinary Shares
CTK
$430K 0.02%
+11,954
New +$542K
MDLA
162
DELISTED
Medallia, Inc.
MDLA
$418K 0.02%
15,000
– –
SPAQ.U
163
DELISTED
Spartan Acquisition Corp. III Units, each consisting of one share of Class A common stock and one-fo
SPAQ.U
$401K 0.02%
+40,000
New +$415K
IVAC
164
DELISTED
Intevac Inc
IVAC
$358K 0.01%
+50,000
New +$334K
HYFM icon
165
Hydrofarm Holdings
HYFM
$8.77M
$302K 0.01%
+500
New +$351K
TRAW icon
166
Traws Pharma
TRAW
$8.08M
$300K 0.01%
+800
New +$302K
HTHT icon
167
Huazhu Hotels Group
HTHT
$13B
$275K 0.01%
+5,000
New +$267K
HTT
168
High Templar Tech Ltd
HTT
$387M
$228K 0.01%
+100,000
New +$239K
CHAQ.WS
169
DELISTED
Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half (
CHAQ.WS
$188K 0.01%
200,000
– –
EUCRW
170
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
$167K 0.01%
+133,332
New +$216K
BMTX.WS
171
DELISTED
BM Technologies, Inc. Warrants, each warrant exercisable for one share of Common Stock at an exercise price of $11.50
BMTX.WS
$142K 0.01%
+71,000
New +$197K
PSTH.WS
172
DELISTED
Pershing Square Tontine Holdings, Ltd. Warrants, exercisable for one share of Class A Common Stock f
PSTH.WS
$136K 0.01%
16,666
– –
CLNNW
173
DELISTED
Clene Inc Warrant
CLNNW
$25K ﹤0.01%
+21,201
New +$24.5K
AMD icon
174
PUT
Advanced Micro Devices
AMD
$796B
– –
-50,000
Closed -$4.59M
ASHR icon
175
CALL
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.6B
– –
-175,000
Closed -$7.01M
5 6
7
8 9

Similar funds

MAM
Moelis Asset Management New York $5.32M AUM
CCM
Compton Capital Management Providence, Rhode Island $4.32M AUM 27.38% 1-Year Est. Return
BGCI
Bertram Growth Capital III Foster City, California $6.05M AUM 39.41% 1-Year Est. Return
CAM
Chatham Asset Management Chatham, New Jersey $376K AUM
EAM
Emso Asset Management London, United Kingdom $255K AUM 6.95% 1-Year Est. Return
SM
SG3 Management Dorado, Puerto Rico $6.45K AUM 61.81% 1-Year Est. Return
TPL
Tao Pro LLC San Francisco, California $13.8M AUM 74.14% 1-Year Est. Return
RC
Resonate Capital San Francisco, California $15.4M AUM 24.26% 1-Year Est. Return

Granite Point Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Granite Point Capital Management held 230 positions worth $2.68B, up 37% from $1.95B the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Granite Point Capital Management deployed $634M of net new capital in Q1 2021, opening 82 new positions and adding to 28 existing holdings. Its largest new stake was bluebird bio: 18,528 shares worth $7.24M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, down from 4.3% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Neuronetics, an estimated $8.13M trimmed.

  • Granite Point Capital Management's largest Q1 2021 buy was bluebird bio: 18,528 shares worth $7.24M.
  • Granite Point Capital Management added most to Baidu in Q1 2021, an estimated $4.7M increase.
  • Granite Point Capital Management's biggest Q1 2021 reduction was Neuronetics, cutting an estimated $8.13M.
  • Granite Point Capital Management fully exited DraftKings in Q1 2021, selling an estimated $11.1M.
  • Granite Point Capital Management's ten largest holdings make up 78% of its $2.68B portfolio in Q1 2021.
  • Granite Point Capital Management opened 82 new positions and closed 51 in Q1 2021.
  • Granite Point Capital Management's portfolio value rose 37% quarter-over-quarter to $2.68B.

Based on Granite Point Capital Management's 13F filing for Q1 2021, filed 12 May 2021.